Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-01

FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for imipramine hydrochloride by Strides Pharma Science Limited, a generic antidepressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imipramine hydrochloride (Imipramine hydrochloride)

Snippet

SUPPL AP for IMIPRAMINE HYDROCHLORIDE (IMIPRAMINE HYDROCHLORIDE)